hu3S193

BIOLOGICAL2 trials

Sponsors

Recepta Biopharma, Instituto do Cancer do Estado de São Paulo

Conditions

Breast CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer

Phase 2

Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

CompletedNCT00617773

Recepta BiopharmaFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Start: 2008-05-31End: 2012-06-30Updated: 2013-11-26

HumanaH - Hu3s193 in the Treatment of Advanced Breast Cancer After Hormonal Therapy

TerminatedNCT01370239

Instituto do Cancer do Estado de São PauloBreast Cancer

Start: 2013-11-30End: 2018-05-25Updated: 2019-10-11

Related Papers

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.

2021-10-113 citations